Diabetic Oxidative Stress and Bone Loss Complications

Review Article | DOI: https://doi.org/10.31579/2640-1045/056

Diabetic Oxidative Stress and Bone Loss Complications

  • Orlando L. Catanzaro 1
  • Nicole Brasquet 1
  • Alejandra Arganaraz 2

1 Dental and Medical School -AOA Univ. Del Salvador.
2 Department of Physiology -Univ. Argentina John F. Kennedy.

*Corresponding Author: Orlando L. Catanzaro, Dental and Medical School -AOA Universidad Del Salvador, Facultad de Ciencias Médicas, Escuela de Odontologia, Cátedra de Fisiología General y Neurofisiologia. Buenos Aires, Argentina.

Citation: Orlando L. Catanzaro, Brasquet N. and Arganaraz A., (2021) Diabetic oxidative stress and bone loss complications, J. Endo and Disor 5(1); DOI:10.31579/2640-1045/056

Copyright: © 2021, Orlando L. Catanzaro, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 30 October 2020 | Accepted: 16 November 2020 | Published: 06 March 2021

Keywords: diabetes mellitus; metabolic disorder; hyperglycemia; osteoclastic; osteoblastic activity

Abstract

Diabetes mellitus is a group of metabolic disorder characterize by and absolute or partial insulin deficiency. Diabetic hyperglycemia is produce by the effect of homeostasis between proteolytic enzymes, their inhibitors and the antioxidants defense that protect and repair vital tissues and molecular components. Bone consist of both component and trabecular bone tissue. Organic matrix and albumin form part of noncollagenous of bone .Initiation of mineralization and collagen fibrils form the phase of mineral matrix. Calcium flux into and out of bone depend of osteoclastic and osteoblastic activity. The remodeling is initiated by resorption and new bone formation at the resorption site. Diabetic complication is a critical factor for bone pathology and could start early inflammatory stage even before hyperglycemia. Diabetic produces bone loss from reduce osteoblast activity. Partly insulin deficiency   produce defective bone remodeling indirect by oxidative stress. The current treatment for defective bone in diabetes state include biophosphonate and cinaciguat. Biphosphonate inhibit bone resorption, but may worsen bone quality. A novel type of activation of sGMP is cinaciguat an NO independent activator of oxidative GC, increase c GMP synthesis on diabetic and restore proliferation and survival of osteoblasts. Chronic hyperglycemia interferes with the oseointegration of implants in diabetics. Both diabetic and aging plays a role in abnormal differentiation of osteroblasts. In diabetic patients may improve the oral health to have a positive impact if optimal glycemic control is emphasized. However with cinaciguat present as a novel paradigm enhancing bone formation under hyperglycemia and protect bone implants.

Introduction

Diabetic mellitus is a group of metabolic disorders characterized by an absolute or partial insulin deficiency [1]. There are 4 types of diabetes: (i) type 1 diabetes, caused by destruction of pancreatic β-cells; (ii) type 2 diabetes, which is at least 90% of cases (occurs as a result of progressive defect in insulin secretion;(iii) gestational diabetes (occurs In the second or third trimester of pregnancy); and (iv) diabetes of other causes pancreatic anomalies, (eg. pancreatic fibrosis, drugs or chemical –induced or organ transplantation) [2]. A loss  of homeostatic balance between proteolytic  enzymes (neutrophil elastase) and their inhibitors (alfa1-antitrypsin) and reactive oxygen species (ROS) and the antioxidant defense that protect and repair vital tissue, cell, and molecular components  is believe to be responsible for the effect of diabetic hyperglycemia. The results from bone loss with the changes in remodeling during normal aging may be accelerated by extrinsic and intrinsic factors. Although bone appears inert, it is a dynamic tissue that receives about 10% of the cardiac output and remodels throughout life [3]. Bone consist of both compact and trabecular bone. The extracellular bone components include a solid mineral phase associated with 90-95 % of organic type 1 and collagen matrix. Noncollagenous is part of organic matrix   and   contains albumin, cell attachment/ signaling proteins as osteopontin and fibronectin, calcium binding proteins and osteocalcim, biglycan and decorin. The proteins of serum are responsible for the organization of collagen fibrils, initiation of mineralization and the mineral phase to the matrix. The skeleton contains over 99% of the calcium in the adult body. There are high rates of calcium flux into and out of bone, mediated by osteoblastic and osteoclastic activity, the 0.5-1-0% of exchangeable calcium is within then extracellular fluid.   

Calcium channels can be activated by hormones, metabolites or neurotransmitters affecting the 50% of total serum calcium that is ionized.

The ionized calcium is concentrated in the extracellular fluid by across renal and intestine epithelia mediated by the effect of parathyroid hormones, D3 vitamin and calcium. In the control of calcium and phosphorus homeostasis, evidences has been demonstrated that vitamin D3 and is synthetic analogs play a multiple functional role in the enhancement of antimicrobial peptide, expression and immunomodelatory actions [4, 5]. Current evidence indicates that Vit. D mediate activation and regulate genes that mediate osteoblast and osteolast functions [6]. Healthy bone models and remodels occurs throughout life as a dynamic effect of bone tissue. The skeleton increases in size in response in the stresses placed upon it. This involves new bone formation that is independent of tissue resorption and in this form can assume a new shape or cortical thickening. The remodeling is initiated by resorption and by new bone formation in the same place of resorptive site. Mechanical bone stresses are transmitted to osteoclast or osteoblast or to their precursors by osteocytes. Bone resorption reflex the sum of osteoclast recruitment and death, and the relation of the average cell degrades matrix [7]. Diabetes mellitus is associated with overproduction of inflammatory cytokines and oxidative stress in response to the state of hyperglycemia [8, 9], and interleukin-1β and tumor necrosis factor (TNF-alfa) that leads to the destruction of pancreatic β-cells [10]. Diabetic complications, including bone pathology, could start in develop the early inflammatory stages of the disease, even before establish the hyperglycemia and /or the glucosuria based diagnosis for diabetes [11]. Bone loss are frequent complications of diabetes [1]. Bone loss in diabetes type 1 is mainly from reduced osteoblast activity, thus, current osteoporosis therapies aimed at inhibiting osteoclast are inadequate [12, 13]. In diabetes type 2 bone formation decreased and increase facture risk, but bone mineral density may normal or increased, while bone quality is impaired [14]. Inflammatory  processes are well known to interact with remodeling of bone tissue in the vicinity , causing  bone enhanced  rate of bone resorption  and new bone formation with the former  usually being dominant [15, 16]. Pro-inflammatory mediators formed by the kallikrein-kinin system can stimulate bone resorption and synergistically potentiate bone resorption induced by IL-1 β and TNF-alfa. Bone loss due to increased number of activity resorbing osteclasts observed in periodontal disease and rheumatoid arthritis and diabetes is usually considered being caused by excess of cytokines stimulating osteoclast genesis compared to those with inhibitory effects. Stimulatory  cytokines include interleukin-1(IL-1),IL-6,IL-11, IL-17,  leukaemia inhibitory factor(LIF), oncostatin M(OSM), tumor necrosis factor (TNF-alfa) and transforming growth factor-β(TGF-β), and the group inhibitory  cytokines  belongs IL-4, IL-10, IL-13, interferon –ϒ(ITF-ϒ ) [17, 18]. Kinis can stimulate bone resorption in vitro [19, 20] and may more important synergistically potentiate the bone resorption effect of IL-1 an effect synergistic enhancement of prostaglandin biosynthesis [21]. Kinins have been known in a variety of biological effects including cardiovascular homeostasis inflammation, nociocepcion and bone resorption [22, 23, and 18]. Kinins are formed from kininogen either by plasma kallikrein, which is activated early in the coagulation cascade, or tissue kallikrein, which is activated   by proteases at injured sites [24]. Their mediate biological effects by acting on two types of receptors namely B1 and B2. Molecular cloning of the bradykinin (BKB1-R) B1R receptors and the B2R receptors (BKB2 –R) from a variety of species including humans, revealed that they belong to the family of G protein-couple receptors [25]. The BKB2-R mediate many of the physiological effects of kinins are constitutively expressed and involved in the acute phase of the inflammation. The BKB1-R, usually absent in normal tissues, are induced an over-expressed during tissue injury and following treatment with inflammatory mediators like endotoxin and cytokines. Furthermore the enhancement of B1 and B2 receptors expression and IL-1 β and TNF-ϒ was not only observed in the human osteoblasts cell but also in the intact mouse calvarial bones and primary culture of human gingival fibroblast [26]. Partly insulin deficiency produce defective bone remodeling in diabetes type 1, but current evident indicates that hyperglycemia induce oxidative stress [27]. Increased reactive oxygen species (ROS) and decreased antioxidants defense mechanism contribute to diabetic tissue damage and bone loss [28, 29]. Patients with type 2 diabetes  have decreased  bone formation and  increased fracture risk ,but bone mineral density may be normal  or increased, ,while bone quality is impaired [30]. Compared with other complications, diabetic disease increase the osteoporosis in bone fragility and fracture [31]. Current experimental evidences suggest that durable hyperglycemia, the most remarkable character of diabetes, could impair bone regeneration and delay bone healing rates [32].  There is an increase of alveolar ridge reabsorption in edentulous patients with osteoporosis [33]. Greater alveolar crystal height loss is noted with osteoporosis and osteopenia [34]. Osteoporosis and osteopenia are associated to diabetes and periodontitis, attachment loss and gingival recession [35]. Induced bone mineral density was associated with increased clinical attachment loss [36]. On the other hand weak or not significant   association between systemic bone mineral and clinical attachment loss was observed [37]. However an association between osteoporosis and clinical attachment loss provided stronger evidences [38]. In postmenopausal women was found that periodontal disease and osteoporosis was associated with lower vitamin D and higher concentrations of RANKL and osteoprotegerin [39]. Between others, reduced bone mineral density is a critical risk factor for periodontitis rather than a casual factor between periodontal disease and reduced bone mineral density. As the natural teeth are more prone to loss and, as well also, osteoporosis, in diabetic periodontitis, two components to ameliorate all adverse effect of periodentits on bone can be describe. The current medications for osteoporosis include   calcium, vitamin D, parathyroid hormone, selective estrogen receptor modulators, calcitonin, bisphosphonates and cinaciguat. With increasing longevity, it is important to remember that osteoporosis in diabetes is common to both sex. Clinical therapy for osteoporosis is a lifelong - intervention.  Diabetic hyperglycemia could delay bone healing rates, which is critical for the osseointegration of dental implants. Bisphosphonates are analogs of inorganic pyrophosphates. Biophosphonates inhibit bone resorption, improve bone mineral density but may worsen bone quality by repressing bone formation. There are differences in the chemical and, physical structure of bisphosphonates, and these differences may explain variations in clinical observations, as potency at enzymatic level, binding affinity, distribution accumulation and release. Bisphosphonates of low affinity do not bind as tightly on the surface of the bone for removal by osteoclasts  and the drug comes off easily from bone and its effect may shorter in duration.   Bisphosphonate is derived from the base of the drug, with two phosphonate (PO3) groups covalent linked to a central carbon. The carbon atom confers resistance to hydrolysis with two side chains.  The short side –chain usually has a hydrolysis moiety and provide a strong affinity for calcium crystal and bone mineral. The long- side –chain determines the mode of action and the strength of the bisphosphonate. Bisphosphonates have low intestinal absorption and are excreted via renal. Bisphosphonates inhibition osteoclasts depend by two mechanisms: if long side –chain contains or not nitroside groups. When lack a nitrogen in the side–chains are metabolized by osteoclasts, interfere with osteoclasts and induce apoptosis. On the other hand the side with nitrogen contains side groups reduced osteoclasts recruitment and induced osteoblasts to produce an osteoclast inhibiting factor. In experimental animals, bisphosphonate (alendronate) has been showed to inhibit repair of normal micro damage, so micro damage accumulation may occur [40]. To date bisphosphonates trials, specific gains in bone quality architecture, turnover, damage accumulation and mineralization have not been reported in human maxilla or mandibule. As a matter of fact hyperglycemia induces oxidative stress and loss bone mineral density and reduce bone mass.  These two factors could impair bone regeneration which is critical for the osseointegration implants in patients with diabetes [41]. More effective methods in reverse the bone loss in diabetes could be an important factor. As a vital molecule NO can diffuse into target cells and activate intracellular receptor, the soluble guanylate cyclase (sGC). Cyclic guanosine monophosphate -5 (cGMP) is generated by cytoplasmic sGC and hydrolyzed  by phosphodiesterase -5 (PDE5) which stimulates protein kinase G(PKG), and produce a series of biological effects  as reversing oxidative stress, inducing osteoblast generation [42]. In diabetic conditions existing evidences that the cGMP/PKG II could be disturbed [43], such as increased expression of PDES and decreased bioavailability of cGMP [44] soluble guanidine cyclase (sGC) drug have been discovered to resist interfered cGMP/PKG II pathway. A novel type of activator of sGC is Cinaciguat (Bay 58-2667), an NO-independent activator of oxidative guanylate cyclase increase cGMP synthesis under diabetic conditions and restore proliferation, differentiation, and survival of osteoblasts. The effect of the drug increase trabecular and cortical bone in type 1 mice by improving bone formation and osteoblasts. In type 1 diabetes bone loss is due from reduced osteoblast activity. On the other hand defective bone remodeling in diabetes is partly due to insulin deficiency. Insulin requires NO/cGMP/PKGII signaling for proliferative effect in osteoblasts. Under hyperglycemia conditions decrease insulin activation of the NO/cGMP/PKGII in osteoblasts expose to high glucose .Restoring cGMP synthesis reduces oxidative stress, recovers osteoblast functions, decreases osteocyte apoptosis, and prevent bone loss in the insulin –deficient mice. According to Joshua et al [45] cinaciguat produce a transient decline in systolic pressure. Research shows that cinaciguat could improve cardiac dysfunction in type 1 diabetic rats [46], which indicated that it may play a protective role in glucotoxicity environments. Have been demonstrated that cinaciguat could reverse the damage of osteoblasts caused by high glucose and protect the osteogenic function in TID mice [47]. Osseointegtration is a combination of living bone tissue and implants and the first stage of bone implants interactions is essential for the formation of osseointegration interface. It is difficult to explain the molecular effects of cinaciguat on osteointegration under hyperglycemia condition. Studies in diabetic rats (Zucker or STZ) showed that chronic hyperglycemia interferes with the osseointegration of implants by determining expression of fibronectin and integrin alpha 5-beta -1[48]. Advanced glycation end products accumulate in body tissues with the age’s progression, and under hyperglycemic conditions inhibit osseointegration and compromise the biochemical properties of the bone implant interface. Persistent hyperglycemia plays a role in abnormal differentiation of osteoblasts, making bone tissue more susceptible to resorption [49]. Diabetes is associated with peri-implant soft tissue, crystal bone loss and even implant ailure. Implant survival and primary stability parameters in diabetes conditions varying with hemoglobin A1c, and increase in proportion with the rising hemoglobin A1c levels. Peri-implant plaque index, bleeding on probing depth and crest bone loss are significantly higher in diabetic than in control. In diabetic patients may improve the oral health to have a positive impact if optimal glycemic control   is emphasized. No/cGMP/PKG pathways activator with cinaciguat present a novel paradigm for enhancing bone formation under conditions of hyperglycemia and oxidative stress.

References

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias

Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.

img

Rui Tao

Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.

img

Khurram Arshad